• Tidak ada hasil yang ditemukan

symptoms of the patients with bronchectasis due to sulfur mustard gas inhalation.

N/A
N/A
Protected

Academic year: 2023

Membagikan "symptoms of the patients with bronchectasis due to sulfur mustard gas inhalation."

Copied!
4
0
0

Teks penuh

(1)

1

Clinical Trial Protocol

Iranian Registry of Clinical Trials

06 Nov 2022

Evaluation of the effects of Colchicin and Simvastatin combination therapy on the improvement of clinical and laboratory signs and

symptoms of the patients with bronchectasis due to sulfur mustard gas inhalation.

Protocol summary

Summary

The aim of this study is evaluation of the effects of Colchicin and Simvastatin combination therapy on the improvement of clinical and laboratory signs and symptoms of the patients with bronchectasis due to sulfur mustard gas inhalation. This is a double blind randomized phase III clinical trial. We will be recruited patients with bronchectasis due to sulfur mustard gas inhalation who will be referred to the pulmonary clinics affiliated with Shiraz University of Medical Sciences, Shiraz, Iran. The main inclusion criteria are exposure to mustard gas during the Iran-Iraq war and suffering from bronchectasis (confirmed with CT scan). The main exclusion criteria are using Statins or Colchicin in the last 3 months of study starting time; patients with

bronchectasis without lung injury due to sulfur mustard gas and smoking. We will enroll 50 patients with mustard gas induced bronchectasis. Participants will randomly be assigned into intervention and placebo groups and will receive Simvastatin (10 mg) and Colchicine (10 mg) per day for 3 months in intervention group and two starch tablets per day for 3 months in placebo group. As the primary outcome of our study, lung function, clinical signs and symptoms of the patients and the levels of IgE, IgM, IgA and IgG will be assessed before and after intervention. Also, we will consider health-related quality of life as secondary outcomes.

General information

Acronym

IRCT registration information

IRCT registration number: IRCT2015060322547N1 Registration date: 2015-10-23, 1394/08/01 Registration timing: retrospective

Last update:

Update count: 0 Registration date

2015-10-23, 1394/08/01 Registrant information

Name Ali Kooshki

Name of organization / entity Shiraz Medical University Country

Iran (Islamic Republic of) Phone

+98 71 3633 1253 Email address

[email protected] Recruitment status

Recruitment complete Funding source

Vice chancellor for research Shiraz University of Medical Sciences

Expected recruitment start date 2015-05-22, 1394/03/01

Expected recruitment end date 2015-09-23, 1394/07/01 Actual recruitment start date

empty

Actual recruitment end date empty

Trial completion date empty

Scientific title

Evaluation of the effects of Colchicin and Simvastatin combination therapy on the improvement of clinical and laboratory signs and symptoms of the patients with bronchectasis due to sulfur mustard gas inhalation.

(2)

2 Public title

Effects of Colchicin and Simvastatin combination therapy on the improvement of the patients with bronchectasis due to sulfur mustard gas inhalation.

Purpose Treatment

Inclusion/Exclusion criteria

Inclusion criteria: Exposure to mustard gas during the Iran-Iraq war and have suffered from bronchiectasis (confirmed with CT scan). Exclusion criteria: Using Statins or Colchicin in the last 3 months of study starting time; Patients with bronchectasis without lung injury due to sulfur mustard gas; Exacerbation of symptoms in the past 4 weeks; Connective tissue disease; Sarcoidosis;

Eosinophilic granuloma; Pneumoconiosis; Lymphoma;

Carcinomatous; Smokers.

Age

From 45 years old to 90 years old Gender

Male Phase

3

Groups that have been masked No information

Sample size

Target sample size: 50

Randomization (investigator's opinion) Randomized

Randomization description Blinding (investigator's opinion)

Double blinded Blinding description Placebo

Used Assignment

Parallel

Other design features

Randomization will be done by block randomization in blocks of four in order of enrollment.

Secondary Ids empty

Ethics committees

1

Ethics committee

Name of ethics committee

Ethics committee of Shiraz University of Medical Sciences

Street address

Zand street, Shiraz University of Medical Sciences City

Shiraz Postal code Approval date

2015-04-19, 1394/01/30

Ethics committee reference number IR.SUMS.REC.1394.15

Health conditions studied

1

Description of health condition studied Other COPD due to sulfate mustard gas ICD-10 code

J44

ICD-10 code description

Other chronic obstructive pulmonary disease

Primary outcomes

1

Description lung function Timepoint

before intervention - 3 month after intervention Method of measurement

spirometry

2

Description

clinical signs and symptoms of the patients Timepoint

before intervention - 3 month after intervention Method of measurement

history and physical examinations

3

Description

levels of IgE, IgM, IgA and IgG Timepoint

before intervention - 3 month after intervention Method of measurement

Immunoelectrophoresis

Secondary outcomes

1

Description

health-related quality of life Timepoint

before and 3 months after intervention Method of measurement

the St George’s Respiratory Questionnaire

Intervention groups

1

Description

Intervention group: Simvastatin (10 mg) and Colchicine (10 mg) per day for 3 months

Category

Treatment - Drugs

(3)

3

2

Description

Placebo group: two starch tablets per day for 3 months Category

Treatment - Drugs

Recruitment centers

1

Recruitment center

Name of recruitment center

Shiraz University of Medical Sciences, Faghihi Hospital, Motahari and Imam Reza Clinic Full name of responsible person

Professor Dr.Ali Emad Street address

Shiraz University of Medical Sciences City

Shiraz

Sponsors / Funding sources

1 Sponsor

Name of organization / entity Shiraz University of Medical Sciences Full name of responsible person

Seyed Basir Hashemi (reseach assistance of shiraz medical university)

Street address

Shiraz University of Medical Sciences City

Shiraz Grant name

Grant code / Reference number

Is the source of funding the same sponsor organization/entity?

Yes

Title of funding source

Shiraz University of Medical Sciences Proportion provided by this source

100

Public or private sector empty

Domestic or foreign origin empty

Category of foreign source of funding empty

Country of origin

Type of organization providing the funding empty

Person responsible for general inquiries

Contact

Name of organization / entity Shiraz University of Medical Sciences Full name of responsible person

Professor Dr.Ali Emad

Position Professor

Other areas of specialty/work Street address

Shiraz University of Medical Sciences City

Shiraz Postal code Phone

+98 917 719 0079 Fax

Email

[email protected] Web page address

Person responsible for scientific inquiries

Contact

Name of organization / entity Shiraz University of Medical Sciences Full name of responsible person

Professor Position

Specialty Lung

Other areas of specialty/work Street address

Shiraz University of Medical Sciences City

Shiraz Postal code Phone

+98 917 719 0079 Fax

Email

[email protected] Web page address

Person responsible for updating data

Contact

Name of organization / entity Shiraz University of Medical Sciences Full name of responsible person

Dr.Ali Kooshki Position

Assistant of Specialty Lung Other areas of specialty/work Street address

Shiraz University of Medical Sciences City

Shiraz Postal code Phone

+98 71 3633 1253 Fax

Email

[email protected] Web page address

(4)

4

Sharing plan

Deidentified Individual Participant Data Set (IPD) empty

Study Protocol empty

Statistical Analysis Plan empty

Informed Consent Form empty

Clinical Study Report empty

Analytic Code empty Data Dictionary

empty

Referensi

Dokumen terkait

General information Acronym IRCT registration information IRCT registration number: IRCT2014102719694N1 Registration date: 2015-05-10, 1394/02/20 Registration timing:

General information Acronym IRCT registration information IRCT registration number: IRCT2014102719694N1 Registration date: 2015-05-10, 1394/02/20 Registration timing: